News
The number of overdose deaths among pregnant and postpartum women has seen a significant rise.
The National Institute on Drug Abuse (NIDA) revealed a substantial surge in drug overdose deaths among pregnant and recently postpartum women aged 10 to 44 from 2018 to 2021. Notably, fatalities in the 35 to 44 age group more than tripled during this period, as indicated by data released on Wednesday and published in JAMA
Past-Year Drug Use Reported by 1 in 4 People in the USA
About 1 in 4 people in the US who are at least 12 years of age used illicit drugs within the past year and more than 1 in 6 had a substance use disorder (SUD) during the same period, according to data from the 2022 National Survey on Drug Use and Health (NSDUH).Results of the
An opioid-like drink is masquerading as a wholesome alcohol alternative
When Krista Marquick discovered kratom, it filled a hole in her life that quitting alcohol had left — kratom is often served at specialized bars, so it provided a way to socialize with friends and unwind after work without, she thought, the risk of addiction. Within a few months, Marquick found herself with a brand
Fentanyl Analog Detected in 12 States Carfentanil Re-Emerges
A Millennium Health Signals Alert released Thursday found carfentanil in urine 35 times in 12 states in 2023, the potent fentanyl analog used in veterinary medicine as a large animal tranquilizer but not approved for human use. Carfentanil, 100 times more potent than fentanyl, was detected in a urine drug test screening just once in
OUD Treatment Retention Improved by Telehealth-Based Initiation
According to a study released on Wednesday by the National Institute on Addictive Disorders (NIDA), patients with opioid use disorder (OUD) who begin buprenorphine treatment by telehealth are more likely to remain engaged with treatment longer than patients who begin treatment in a non-telehealth environment. In JAMA Network Open, researchers analyzed Medicaid data from 2019
Medications prescribed for OUD with concomitant polysubstance use may jeopardize recovery
Medications have been proven to be effective for treating opioid use disorders; however, practitioners should be aware of concurrent use of non-prescribed, illicit substances that could adversely affect treatment. At the recent Cape Cod Symposium on Addictive Disorders, Kelly Olson, PhD, director of clinical affairs for Millennium Health, shared key considerations for monitoring patients’ medications
GET HELP NOW
The addiction recovery and rehabilitation expert is standing by to answer your questions about our addiction treatment and rehabilitation program.